2016 SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: A report of the Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology

Journal of Cardiovascular Computed Tomography

Volumn 11, Issue 1, 2017, Pages 74-84

  Hecht, Harvey S ^a   Cronin, Paul ^b   Blaha, Michael J ^c   Budoff, Matthew J ^d   Kazerooni, Ella A ^b   Narula, Jagat ^e   Yankelevitz, David ^f   Abbara, Suhny ^g  

^a LENOX HILL HEART AND VASCULAR INSTITUTE   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f MOUNT SINAI MEDICAL CENTER   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Computed tomography; Coronary artery calcium; Coronary artery disease

Indexed keywords

AGATSTON SCORE; ARTICLE; CARDIOVASCULAR DISEASE ASSESSMENT; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIUM SCORE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; INFORMATION PROCESSING; MEDICAL EDUCATION; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONCONTRAST NONCARDIAC CHEST COMPUTER ASSISTED TOMOGRAPHY; ORDINAL SCORING; PATIENT CARE; PATIENT EDUCATION; PATIENT SELECTION; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; SHARED DECISION MAKING; ADULT; AGED; CONSENSUS; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; INCIDENTAL FINDING; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; STANDARDS; THORAX RADIOGRAPHY; VASCULAR CALCIFICATION; X-RAY COMPUTED TOMOGRAPHY;

ADULT; AGED; CONSENSUS; CORONARY ARTERY DISEASE; HUMANS; INCIDENTAL FINDINGS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOGRAPHY, THORACIC; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; VASCULAR CALCIFICATION;

EID: 85007499756     PISSN: 19345925     EISSN: 1876861X     Source Type: Journal    
DOI: 10.1016/j.jcct.2016.11.003     Document Type: Article

References (79)

1. 1 WHO Fact Sheet, The Top 10 Causes of Death. May 2014 www.WHO.int Accessed September 16.2016.
2. 2 Hecht, H.S., Coronary artery calcium scanning: past, present and future. J Am Coll Cardiol Img 8 (2015), 579–596.
3. 3 Grundy, S.M., Cleeman, J.I., Merz, C.N., et al. Coordinating committee of the national cholesterol education program. Implications of recent clinical trials for the national cholesterol education program adult treatment panel IIIguidelines. J AmColl Cardiol 44 (2004), 720–732.
4. 4 Stone, N.J., Robinson, J., Lichtenstein, A.H., et al. American College of cardiology/american heart association task Force on practice guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the american College of cardiology/american heart association task Force on practice guidelines. J AmColl Cardiol 63 (2014), 2889–2934.
5. 5 Piepoli, M.F., Hoes, A.W., Agewall, S., Albus, C., et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice Euro Heart J 2016. 2016 23 May 2016 http://dx.doi.org/10.1093/eurheartj/ehw106 ehw106 First published online.
6. 6 Berrington de Gonzalez, A., Mahesh, M., Kim, K.P., et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med [Research Support. Non-US Gov't 169:22 (2009), 2071–2077.
7. 7 Moyer, V.A., on behalf of the U.S. Preventive Services Task Force. Screening for lung cancer: U.S. Preventive Services task Force recommendation statement. Ann Intern Med 160 (2014), 330–338.
8. 8 National Coverage Analysis (NCA) for Screening for Lung cancer with Low Dose Computed Tomography (LDCT) (CAG-00439N). Available at: http://www.cms.gov/medicare-coverage-database/details/ncedetails.aspx?NCAld=272&NcaName+Screening+for+Lung+Cancer+with+Low+Does+Computed+Tomography+ (LDCT)&MEDCACld=68&IsPopup=y&.
9. 9 Hecht, H.S., Henschke, C.I., Yankelevitz, D., Fuster, V., Narula, J., Combined detection of coronary artery disease and lung cancer. Eur Heart J 35 (2014), 2792–2796.
10. 10 American College of Radiology, Lung CT screening reporting and data system (Lung-RADS). Available at: http://www.acr.org/Quality-Safety/Resources/LungRADS (Accessed July.7.2016).
11. 11 Greenland, P., Alpert, J.S., Beller, G.A., et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the american College of Cardiology foundation/american heart association task Force on practice guidelines. J Am Coll Cardiol 56 (2010), 50–103.
12. 12 Paixao, A.R.M., Berry, J.D., Neeland, I.J., et al. Coronary artery calcification and family history of myocardial infarction in the Dallas heart study. JACC Cardiovasc Imaging 7 (2014), 679–686.
13. 13 Elias-Smale, S.E., Proença, R.V., Koller, M.T., et al. Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. J Am Coll Cardiol 56 (2010), 1407–1414.
14. 14 Arad, Y., Goodman, K.J., Roth, M., Newstein, D., Guerci, A.D., Coronary calcification, coronary disease risk factors, C-Reactive protein, and atherosclerotic cardiovascular disease EventsThe St. Francis heart study. J Am Col Cardiol 46 (2005), 158–165.
15. 15 Detrano, R., Guerci, A.D., Carr, J.J., et al. Coronary calcium as a predictor of coronary events in four racial orcethnic groups. N Engl J Med 358 (2008), 1336–1345.
16. 16 Erbel, R., Mohlenkamp, S., Moebus, S., et al. Coronarycrisk stratification, discrimination, and reclassificationcimprovement based on quantification of subclinical coronarycatherosclerosis. Heinz Nixdorf recall study.J Am Coll Cardiol 56 (2010), 1397–1406.
17. 17 Nakanishi, R., Li, D., Blaha, M.J., Whelton, S.P., Darabian, S., Flores, F.R., Dailing, C., Blumenthal, R.S., Nasir, K., Berman, D.S., Budoff, M.J., All-cause mortality by age and gender based on coronary artery calcium scores. Eur Heart J Cardiovasc Imaging, 2015 Dec 24 pii: jev328. [Epub ahead of print] PubMed PMID: 26705490 http://dx.doi.org/10.1093/ehjci/jev328.
18. 18 Malik, S., Budoff, M., Katz, R., Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the Multi-Ethnic Study of Atherosclerosis. Diabetes Care 34 (2011), 2285–2290.
19. 19 Yeboah, J., McClelland, R.L., Polonsky, T.S., et al. Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals. JAMA 308 (2012), 788–795.
20. 20 McClelland, R.L., Jorgensen, N.W., Budoff, M., et al. 10-Year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors: derivation in the MESA (Multi-Ethnic study of atherosclerosis) with validation in the HNR (Heinz nixdorf Recall) study and the DHS (Dallas heart study). J Am Coll Cardiol 66 (2015), 1643–1653.
21. 21 Martin, S.S., Blaha, M.J., Blankstein, R., et al. Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis. Circulation 129 (2014), 77–86.
22. 22 Miedema, M.D., Duprez, D.A., Misialek, J.R., et al. Use of coronary artery calcium testing to guide aspirin utilization for primary prevention: estimates from the multi-ethnic study of atherosclerosis. Circ Cardiovasc Qual Outcomes 7 (2014), 453–460.
23. 23 Darabian, S., Luo, Y., Homat, A., et al. CAC score as a possible criterion for administration of angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers: the MultiEthnic Study of Atherosclerosis. Coron Artery Dis 26 (2015), 678–685.
24. 24 Bittencourt, M.S., Blaha, M.J., Blankstein, R., et al. Polypill therapy, subclinical atherosclerosis, and cardiovascular events-implications for the use of preventive pharmacotherapy: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 63 (2014), 434–443.
25. 25 Valenti, V., B OH, Heo R., et al. A 15-Year warranty period for asymptomatic individuals without coronary artery calcium: a prospective follow-up of 9,715 individuals. JACC Cardiovasc Imaging 8 (2015), 900–909.
26. 26 Roberts ET, Horne A, Martin SS, et al. Cost-effectiveness of coronary artery calcium testing for coronary heart and cardiovascular disease risk prediction to guide statin allocation: the Multi-Ethnic Study of Atherosclerosis (MESA). PLoS One. 2015 Mar 18;10(3):e0116377.
27. 27 Elias-Smale, S.E., Proenc, R.V., Koller, M.T., et al. Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. J Am Coll Cardiol 56 (2010), 1407–1414.
28. 28 Polonsky, T.S., McClelland, R.L., Jorgensen, N.W., et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 303 (2010), 1610–1616.
29. 30 Taylor, A.J., Cerqueira, M., Hodgson, J.M., ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. J Am Coll Cardiol 56 (2010), 1864–1894.
30. 31 Goff, D.C. Jr., Lloyd-Jones, D.M., Bennett, G., 2013 ACC/AHA guideline on the assessment of cardiovascular risk. J Am Coll Cardiol 63 (2014), 2935–2959.
31. 32 Kalia, N.K., Miller, L.G., Nasir, K., et al. Visualizing coronary calcium is associated with improvements in adherence to statin therapy. Atherosclerosis 185 (2006), 394–399.
32. 33 Orakzai, R.H., Nasir, K., Orakzai, S.H., et al. Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors. Am J Cardiol 101 (2008), 999–1002.
33. 34 Taylor, A.J., Bindeman, J., Feuerstein, I., et al. Community-based provision of statin and aspirin after the detection of coronary artery calcium within a community-based screening cohort. J Am Coll Cardiol 51 (2008), 1337–1341.
34. 35 Rozanski, A., Gransar, H., Shaw, L.J., et al. Impact of coronary artery calcium scanning on coronary risk factors and downstream testing: the EISNER (Early Identification of Subclinical Athero, sclerosis by Noninvasive Imaging Research) prospective randomized trial. J Am Coll Cardiol 57 (2011), 1622–1632.
35. 36 Brugts, J.J., Yetgin, T., Hoeks, S.E., The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ, 338, 2009, b2376 jev328 http://dx.doi.org/10.1093/ehjci/jev328.
36. 37 De Koning, H.J., Van Der Aalst, C.M., Van Aerde, M.A., Ijkema, R., Van Bruggen, R., Oudkerk, M., Design and recruitment of the ROBINSCA trial: screening for cardiovascular disease. Ongoing randomized trial on the effect of coronary calcium on clinical outcomes. Euro Heart J, 36, 2015, S985.
37. 38 ACR–SCBT-MR–SPR practice parameter for the performance of thoracic computed tomography (CT) Res. 10 – 2013, Amended 2014 (Res. 39).
38. 39 International Early Lung Cancer Action Program Investigators, Henschke, C.I., Yankelevitz, D.F., Libby, D.M., Pasmantier, M.W., Smith, J.P., et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355 (2006), 1763–1771.
39. 40 National Lung Screening Trial Research Team, Aberle, D.R., Adams, A.M., Berg, C.D., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. New Engl J Med 365 (2011), 395–409.
40. 41 Black, W.C., Gareen, I.F., Soneji, S.S., et al. Gatsonis, for the national lung screening trial research team. Cost-effectiveness of CT screening in the national lung screening trial. N Engl J Med 371 (2014), 1793–1802.
41. 42 National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: lung cancer screening. Version, 1, 2013 Formal recognition of CT as a screening tool for lung cancer http://www.respiratory-thessaly.gr/assets/lung_screening%201. 2013.pdf (Accessed September.19.2017).
42. 43 Detterbeck, F.C., Lewis, S.Z., Diekemper, R., Addrizzo-Harris, D., Alberts, W.M., Executive summary: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143:5_suppl (2013), 7S–37S.
43. 44 Wender, R., Fontham, E.T.H., Barrera, E., American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 63 (2013), 106–117.
44. 45 Jaklitsch, M.T., Jacobson, F.L., Austin, J.H., et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 144 (2012), 33–38.
45. 46 American Lung Association. Providing Guidance on Lung cancer Screening to Patients and Physicians. April 23, 2012 http://www.lung.org/lung-disease/lung-cancer/lung-cancer-screeningguidelines/lung-cancer-screening.pdf (Accessed September.19.2016).
46. 47 Williams, K.A. Sr., Kim, J.T., Holohan, K.M., Frequency of unrecognized, unreported, or underreported coronary artery and cardiovascular calcification on noncardiac chest CT. J Cardiovasc Comput Tomogr 7 (2013), 167–172.
47. 48 Uretsky, S., Chokshi, N., Kobrinski, T., et al. The interplay of physician awareness and reporting of Incidentally found coronary artery calcium on the clinical management of patients who underwent noncontrast chest computed tomography. Am J Cardiol 115 (2015), 1513–1517.
48. 49 http://www.acr.org/∼/media/ACR/Documents/PDF/QualitySafety/NRDR/Lung%20Cancer%20Screening%20Practice%20Registry/Exam%20Form.pdf (Accessed September.19.2016).
49. 50 http://www.acraccreditation.org/Modalities/CT (Accessed September.19.2016).
50. 51 http://www.aapm.org/pubs/CTProtocols (Accessed September.19.2016).
51. 52 Hecht, H.S., de Siqueira, M.E.M., Cham, M., et al. Low versus standard dose coronary artery calcium scanning. Eur Heart J Cardiovasc Imaging 16 (2015), 358–363.
52. 53 www.arrt.org/Certification/Computed-Tomography (Accessed September.19.2016).
53. 54 http://www.nmtcb.org (Accessed September.19.2016).
54. 55 The Joint Commission. Diagnostic Imaging Requirements. August 10, 2015 Available at: https://www.jointcommission.org/diagnostic_imaging_standards (Accessed July.7.2016).
55. ®. Available at: https://acsearch.acr.org/list (Accessed July.7.2016).
56. 57 AAPM Board of Directors. AAPM Position Statement on the Use of Bismuth Shielding for the Purpose of Dose Reduction in CT Scanning. Policy PP-26-a. February 7, 2012 www.aapm.org/publicgeneral/BismuthShielding.pdf (Accessed July.7.2016).
57. 58 Lee, E.O., Emanuel, E.J., Shared decision making to improve care and reduce costs. N Engl J Med 368 (2013), 6–8.
58. 59 Hecht HS, Blaha M, Nasir K, et al. Clinical indications for coronary artery calcium scoring in asymptomatic patients: expert consensus statement from the society of cardiovascular computed tomography. J Cardiovasc Comput Tomogr: In Press.
59. 60 Kim, S.M., Chung, M.J., Lee, K.S., Choe, Y.H., Yi, C.A., Choe, B.K., Coronary calcium screening using low-dose lung cancer screening: effectiveness of MDCT with retrospective reconstruction. Am J Roentgenol 190 (2008), 917–922.
60. 61 Wu, M.T., Yang, P., Huang, Y.L., et al. Coronary arterial calcification on low-dose ungated MDCT for lung cancer screening: concordance study with dedicated cardiac CT. AmJ Roentgenol 190 (2008), 923–928.
61. 62 Budoff, M.J., Nasir, K., Kinney, G.L., et al. Coronary artery and thoracic calcium on noncontrast thoracic CT scans: comparison of ungated and gated examinations in patients from the COPD gene cohort. J Cardiovasc Comput Tomogr 5 (2011), 113–118.
62. 63 Xie, X., Zhao, Y., de Bock, G.H., et al. Validation and prognosis of coronary artery calcium scoring in nontriggered thoracic computed tomography systematic review and meta-analysis. Circ Cardiovasc Imaging 6 (2013), 514–521.
63. 64 Hughes-Austin, J.M., Dominguez, A., Allison, M.A., et al. Relationship of coronary artery calcium on standard chest computed tomographyscans with mortality. J Am Coll Cardiol Img 9 (2016), 152–159.
64. 65 Takx, R.A.P., de Jong, P.A., Leiner, T., et al. Automated coronary artery calcification scoring in non-gated chest CT: agreement and reliability. PLoS One, 9(3), 2014, e91239, 10.1371/journal.pone.0091239.
65. 66 Jacobs, P.C., Prokop, M., van der Graaf, Y., et al. Comparing coronary artery calcium and thoracic aorta calcium for prediction of all-cause mortality and cardiovascular events on low-dose non-gated computed tomography in a high-risk population of heavy smokers. Atherosclerosis 209 (2010), 455–462.
66. 67 Mets, O.M., Vliegenthart, R., Gondrie, M.J., et al. Lung cancer screening CT-based prediction of cardiovascular events. J Am Coll Cardiol Img 6 (2013), 899–907.
67. 68 Chiles, C., Duan, F., GladishGW, et al. Association of coronary artery calcification and mortality in the National Lung Screening Trial: a comparison of three scoring methods. Radiology 76 (2015), 82–90.
68. 69 Shemesh, J., Henschke, C.I., Shaham, D., et al. Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest predicts deaths from cardiovascular disease. Radiology 257 (2010), 541–548.
69. 70 Htwe, Y., Cham, M., Claudia Henschke, C., et al. Coronary artery calcification on low-dose non gated computed tomography: comparison of Agatston and ordinal scores. Clin Imaging 39 (2015), 799–802.
70. 71 MJ1, Budoff, Nasir, K., McClelland, R.L., et al. Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 53 (2009), 345–352.
71. 72 http://www.mesa-nhlbi.org/Calcium/input.aspx (Accessed September.19.2016).
72. 73 McClelland, R.L., Jorgensen, N.W., Budoff, M., et al. 10-Year coronary heart disease risk prediction using coronary artery calcium and traditional risk factors: derivation in the MESA (Multi-Ethnic study of atherosclerosis) with validation in the HNR (Heinz nixdorf Recall) study and the DHS (Dallas heart study). J Am Coll Cardiol 66 (2015), 1643–1653.
73. 74 http://www.mesa-nhlbi.org/MESACHDRisk/MesaRiskScore/RiskScore.aspx (Accessed September.19.2016).
74. 75 Berland, L.L., Silverman, S.G., Gore, R.M., et al. Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee. J Am Coll Radiol 7 (2010), 754–773.
75. 76 Khosa, F., Krinsky, G., Macari, M., Yucel, E.K., Berland, L.L., Managing incidental findings on abdominal and pelvic CT and MRI, Part 2: white paper of the ACR Incidental Findings Committee II on vascular findings. J Am Coll Radiol 10 (2013), 789–947.
76. 77 Heller, M.T., Harisinghani, M., Neitlich, J.D., Yeghiayan, P., Berland, L.L., Managing incidental findings on abdominal and pelvic CT and MRI, Part 3: white paper of the ACR incidental findings committee II on splenic and nodal findings. J Am Coll Radiol 10 (2013), 833–839.
77. 78 Hoang, J.K., Langer, J.E., Middleton, W.D., et al. Managing incidental thyroid nodules detected on imaging: white paper of the ACR incidental thyroid findings committee. J Am Coll Radiol 12 (2015), 143–150.
78. ®) and national committee for quality assurance. Diagnostic Imaging Performance Measurement Set Am Med Assoc Am Coll Radiology, 2014 http://www.acr.org/∼/media/ACR/Documents/PDF/QualitySafety/Quality%20Measurement/Performance%20Measures/DiagnosticImagingMeasureSet2015.pdf (Accessed September 19 2016).
79. 80 Morgan, T.A., Helibrun, M.E., Kahn, C.E., Reporting initiative of the Radiological Society of North America: progress and new directions. Radiology 273 (2014), 642–645.